Advanced search
Publication Cover
HIV Clinical Trials Volume 2, 2001 - Issue 6
Submit an article Journal homepage
53
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Highly Active Antiretroviral Treatment (HAART) and Health-Related Quality of Life in Naive and Pretreated HIV-Infected Patients

A. CasadoUnitat de Recerca en Resultats Sanitaris, Departament d’Epidemiología Clínica y Salut Pública, Hospital de la Santa Creu y Sant Pau, Barcelona, Spain. [email protected]Correspondence[email protected].
,
E. ConsiglioInfectious Disease ServiceCiutat Sanitaria de Bellvitge, L’Hospitalet, Barcelona, Spain
,
D. PodzamczerInfectious Disease ServiceCiutat Sanitaria de Bellvitge, L’Hospitalet, Barcelona, Spain
&
X. BadiaUnitat de Recerca en Resultats Sanitaris, Departament d’Epidemiología Clínica y Salut Pública, Hospital de la Santa Creu y Sant Pau, Barcelona, Spain. [email protected]
Pages 477-483 | Published online: 02 Feb 2015

REFERENCES

  • Hodgson I. HIV and combination therapy: Meeting the challenge of a new era. Br J Nurs. 1999;8:39–43.
  • Morlat P. The chronicity of HIV infection. Rev Prat. 1999;49:1781–1785.
  • Podzamczer D. Avances en el manejo del paciente infectado por VIH. Madrid: TEAM PHARMA; 1999.
  • Sanders C, Egger M. Reporting on quality of life in randomised controlled trials: Bibliographic study. Br Med J. 1998;317:1191–1194.
  • De Boer JB, van Dam FSAM, Sprangers MAG. Longitudinal study on the quality of life of symptomatic HIV-infected patients in a trial of zidovudine versus zidovudine and interferon-alpha. AIDS. 1993;7:947–953.
  • Scott-Lennox JA, Wu AW, Boyer JG, Ware JE. Reliability and validity of French, German, Italian, Dutch, and UK English translations of the Medical Outcomes Study HIV Health Survey. Med Care. 1999;37:908–925.
  • Holmes WC, Shea JA. Two approaches to measuring qual-ity of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. Qual Life Res. 1999;8:515–527.
  • Smith KW, Avis EN, Mayer KH, Swislow L. Use of the MQ0L-HIV with asymtomatic HIV-positive patients. Qual Life Res. 1997;6:237–247.
  • Badia X, Podzamczer D, Garcia M, LOpez-Lavid C, Consiglio E, and the Spanish MOS-HIV and MQ0L-HIV Validation Group. A randomised study comparing instru-ments for measuring health-related quality of life in HIV-infected patients. AIDS. 1999;13:1727–1735.
  • Badia X, Podzamczer D, Casado A, LOpez-Lavid C, Garcia M, and the Spanish MOS-HIV and MQ0L-HIV Validation Group. Evaluating changes in health status in HIV-infected patients: Medical Outcomes Study-HIV and multidimen-sional quality of life questionnaires. AIDS. 2000;14:1439–1447.
  • Badia X, Baró E. The measurement of health-related quality of life in prospective drug therapy studies in HIV-infected patients. AIDS Rev. 1999;1:213–220.
  • Wu A, Revicki D, Jacobson D, Malitz F. Evidence for reli-ability, validity and usefulness of the Medical Outcomes Study HIV Health Survey (MOS-HIV). Qual Life Res. 1997;6:481–493.
  • Badia X, Casado A. The evaluation of health related quality of life in HIV infected patients in clinical trials. AIDS Cyber J. 2000;3(5):94–101.
  • Badia X, Podzamczer D, López-Lavid C, Garcia My Grupo Español de Validación de los cuestionarios MOS-HIV y MQ0L-HIV. Medicina basada en la evidencia y la validación de cuestionarios de calidad de vida: La version española del cuestionario MOS-HIV para la evaluaciön de la calidad de vida en pacientes infectados por el VIH. Enferm Infecc Microbiol Clin. 1999;17\(suppl 2):103–113.
  • Hengel RL, Watts NB, Lennox JL. Benign symetric lipoma-tosis associated with protease inhibitors. Lancet. 1997;350:1596.
  • Carr A, Samaras K, Burton S, et al. A syndrome of periph-eral lipodistrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12:F51–F58.
  • Henry K, Melroe H, Huebsh J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet. 1998;351:1328–1329.
  • Cohen J. Statistical Power Analysis for the Behavioral Sci-ences. 2nd ed. Hillsdale, NJ: Lawrence Elrbaum Associ-ates; 1988.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.